Cargando…

Pentavalent vaccination in Kenya: coverage and geographical accessibility to health facilities using data from a community demographic and health surveillance system in Kilifi County

BACKGROUND: There is substantial evidence that immunization is one of the most significant and cost-effective pillars of preventive and promotive health interventions. Effective childhood immunization coverage is thus essential in stemming persistent childhood illnesses. The third dose of pentavalen...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogero, Morris, Orwa, James, Odhiambo, Rachael, Agoi, Felix, Lusambili, Adelaide, Obure, Jerim, Temmerman, Marleen, Luchters, Stanley, Ngugi, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040218/
https://www.ncbi.nlm.nih.gov/pubmed/35468754
http://dx.doi.org/10.1186/s12889-022-12570-w
_version_ 1784694289785159680
author Ogero, Morris
Orwa, James
Odhiambo, Rachael
Agoi, Felix
Lusambili, Adelaide
Obure, Jerim
Temmerman, Marleen
Luchters, Stanley
Ngugi, Anthony
author_facet Ogero, Morris
Orwa, James
Odhiambo, Rachael
Agoi, Felix
Lusambili, Adelaide
Obure, Jerim
Temmerman, Marleen
Luchters, Stanley
Ngugi, Anthony
author_sort Ogero, Morris
collection PubMed
description BACKGROUND: There is substantial evidence that immunization is one of the most significant and cost-effective pillars of preventive and promotive health interventions. Effective childhood immunization coverage is thus essential in stemming persistent childhood illnesses. The third dose of pentavalent vaccine for children is an important indicator for assessing performance of the immunisation programme because it mirrors the completeness of a child’s immunisation schedule. Spatial access to an immunizing health facility, especially in sub-Sahara African (SSA) countries, is a significant determinant of Pentavalent 3 vaccination coverage, as the vaccine is mainly administered during routine immunisation schedules at health facilities. Rural areas and densely populated informal settlements are most affected by poor access to healthcare services. We therefore sought to determine vaccination coverage of Pentavalent 3, estimate the travel time to health facilities offering immunisation services, and explore its effect on immunisation coverage in one of the predominantly rural counties on the coast of Kenya. METHODS: We used longitudinal survey data from the health demographic surveillance system implemented in Kaloleni and Rabai Sub-counties in Kenya. To compute the geographical accessibility, we used coordinates of health facilities offering immunisation services, information on land cover, digital elevation models, and road networks of the study area. We then fitted a hierarchical Bayesian multivariable model to explore the effect of travel time on pentavalent vaccine coverage adjusting for confounding factors identified a priori. RESULTS: Overall coverage of pentavalent vaccine was at 77.3%. The median travel time to a health facility was 41 min (IQR = 18–65) and a total of 1266 (28.5%) children lived more than one-hour of travel-time to a health facility. Geographical access to health facilities significantly affected pentavalent vaccination coverage, with travel times of more than one hour being significantly associated with reduced odds of vaccination (AOR = 0.84 (95% CI 0.74 – 0.94). CONCLUSION: Increased travel time significantly affects immunization in this rural community. Improving road networks, establishing new health centres and/or stepping up health outreach activities that include vaccinations in hard-to-reach areas within the county could improve immunisation coverage. These data may be useful in guiding the local department of health on appropriate location of planned immunization centres.
format Online
Article
Text
id pubmed-9040218
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-90402182022-04-27 Pentavalent vaccination in Kenya: coverage and geographical accessibility to health facilities using data from a community demographic and health surveillance system in Kilifi County Ogero, Morris Orwa, James Odhiambo, Rachael Agoi, Felix Lusambili, Adelaide Obure, Jerim Temmerman, Marleen Luchters, Stanley Ngugi, Anthony BMC Public Health Research Article BACKGROUND: There is substantial evidence that immunization is one of the most significant and cost-effective pillars of preventive and promotive health interventions. Effective childhood immunization coverage is thus essential in stemming persistent childhood illnesses. The third dose of pentavalent vaccine for children is an important indicator for assessing performance of the immunisation programme because it mirrors the completeness of a child’s immunisation schedule. Spatial access to an immunizing health facility, especially in sub-Sahara African (SSA) countries, is a significant determinant of Pentavalent 3 vaccination coverage, as the vaccine is mainly administered during routine immunisation schedules at health facilities. Rural areas and densely populated informal settlements are most affected by poor access to healthcare services. We therefore sought to determine vaccination coverage of Pentavalent 3, estimate the travel time to health facilities offering immunisation services, and explore its effect on immunisation coverage in one of the predominantly rural counties on the coast of Kenya. METHODS: We used longitudinal survey data from the health demographic surveillance system implemented in Kaloleni and Rabai Sub-counties in Kenya. To compute the geographical accessibility, we used coordinates of health facilities offering immunisation services, information on land cover, digital elevation models, and road networks of the study area. We then fitted a hierarchical Bayesian multivariable model to explore the effect of travel time on pentavalent vaccine coverage adjusting for confounding factors identified a priori. RESULTS: Overall coverage of pentavalent vaccine was at 77.3%. The median travel time to a health facility was 41 min (IQR = 18–65) and a total of 1266 (28.5%) children lived more than one-hour of travel-time to a health facility. Geographical access to health facilities significantly affected pentavalent vaccination coverage, with travel times of more than one hour being significantly associated with reduced odds of vaccination (AOR = 0.84 (95% CI 0.74 – 0.94). CONCLUSION: Increased travel time significantly affects immunization in this rural community. Improving road networks, establishing new health centres and/or stepping up health outreach activities that include vaccinations in hard-to-reach areas within the county could improve immunisation coverage. These data may be useful in guiding the local department of health on appropriate location of planned immunization centres. BioMed Central 2022-04-25 /pmc/articles/PMC9040218/ /pubmed/35468754 http://dx.doi.org/10.1186/s12889-022-12570-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Ogero, Morris
Orwa, James
Odhiambo, Rachael
Agoi, Felix
Lusambili, Adelaide
Obure, Jerim
Temmerman, Marleen
Luchters, Stanley
Ngugi, Anthony
Pentavalent vaccination in Kenya: coverage and geographical accessibility to health facilities using data from a community demographic and health surveillance system in Kilifi County
title Pentavalent vaccination in Kenya: coverage and geographical accessibility to health facilities using data from a community demographic and health surveillance system in Kilifi County
title_full Pentavalent vaccination in Kenya: coverage and geographical accessibility to health facilities using data from a community demographic and health surveillance system in Kilifi County
title_fullStr Pentavalent vaccination in Kenya: coverage and geographical accessibility to health facilities using data from a community demographic and health surveillance system in Kilifi County
title_full_unstemmed Pentavalent vaccination in Kenya: coverage and geographical accessibility to health facilities using data from a community demographic and health surveillance system in Kilifi County
title_short Pentavalent vaccination in Kenya: coverage and geographical accessibility to health facilities using data from a community demographic and health surveillance system in Kilifi County
title_sort pentavalent vaccination in kenya: coverage and geographical accessibility to health facilities using data from a community demographic and health surveillance system in kilifi county
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040218/
https://www.ncbi.nlm.nih.gov/pubmed/35468754
http://dx.doi.org/10.1186/s12889-022-12570-w
work_keys_str_mv AT ogeromorris pentavalentvaccinationinkenyacoverageandgeographicalaccessibilitytohealthfacilitiesusingdatafromacommunitydemographicandhealthsurveillancesysteminkilificounty
AT orwajames pentavalentvaccinationinkenyacoverageandgeographicalaccessibilitytohealthfacilitiesusingdatafromacommunitydemographicandhealthsurveillancesysteminkilificounty
AT odhiamborachael pentavalentvaccinationinkenyacoverageandgeographicalaccessibilitytohealthfacilitiesusingdatafromacommunitydemographicandhealthsurveillancesysteminkilificounty
AT agoifelix pentavalentvaccinationinkenyacoverageandgeographicalaccessibilitytohealthfacilitiesusingdatafromacommunitydemographicandhealthsurveillancesysteminkilificounty
AT lusambiliadelaide pentavalentvaccinationinkenyacoverageandgeographicalaccessibilitytohealthfacilitiesusingdatafromacommunitydemographicandhealthsurveillancesysteminkilificounty
AT oburejerim pentavalentvaccinationinkenyacoverageandgeographicalaccessibilitytohealthfacilitiesusingdatafromacommunitydemographicandhealthsurveillancesysteminkilificounty
AT temmermanmarleen pentavalentvaccinationinkenyacoverageandgeographicalaccessibilitytohealthfacilitiesusingdatafromacommunitydemographicandhealthsurveillancesysteminkilificounty
AT luchtersstanley pentavalentvaccinationinkenyacoverageandgeographicalaccessibilitytohealthfacilitiesusingdatafromacommunitydemographicandhealthsurveillancesysteminkilificounty
AT ngugianthony pentavalentvaccinationinkenyacoverageandgeographicalaccessibilitytohealthfacilitiesusingdatafromacommunitydemographicandhealthsurveillancesysteminkilificounty